Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

Published:2018-02 Issue:2 Volume:26 Page:456-467
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hung King L.,Meitlis Iana,Hale Malika,Chen Chun-Yu,Singh Swati,Jackson Shaun W.,Miao Carol H.,Khan Iram F.,Rawlings David J.,James Richard G.

Funder

Seattle Children’s Research Institute

Center for Immunity and Immunotherapies

Seattle Children’s Research Institute Program for Cell and Gene Therapy

Children’s Guild Association Endowed Chair in Pediatric Immunology

NIDDK

NCI

NIH

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Competence and competition: the challenge of becoming a long-lived plasma cell;Radbruch;Nat. Rev. Immunol.,2006

2. Humoral immunity due to long-lived plasma cells;Slifka;Immunity,1998

3. Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures;Kim;Gene Ther.,2014

4. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination;Hellebrand;Gene Ther.,2006

5. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors;Frecha;Blood,2009

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28

2. Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing;Molecular Therapy;2024-08

3. Blunting specific T-dependent antibody responses with engineered “decoy” B cells;Molecular Therapy;2024-08

4. Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells;Stem Cell Research & Therapy;2024-07-29

5. Reprogramming human B cells with custom heavy-chain antibodies;Nature Biomedical Engineering;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3